Steven H Stein
CIK 1673776 · CMO & Head of Late-Stage Dev. · last filed 2026-05-20
Steven H Stein is a CMO & Head of Late-Stage Dev. who has filed 70 SEC Form 4 insider transactions across 4 companies since 2016. The most recent filing, for INCY, was dated May 20, 2026. Across all open-market trades the lifetime net is −$24.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $8.5M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$8.50M
4
70
-$24.88M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| INCY | CMO & Head of Late-Stage Dev. | 78,327 | $108.53 | $8.50M | -$24.88M | 59 | 2026-05-20 |
| Repare Therapeutics Inc. (RPTX) Delisted | Director | — | $2.65 | — | $0 | 1 | 2024-06-20 |
| Theseus Pharmaceuticals, Inc. (THRX) Delisted | Director | — | $4.06 | — | $0 | 3 | 2024-02-14 |
| KURA | Director | — | $9.05 | — | $0 | 7 | 2022-06-23 |
Recent Filings
70 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-20 | INCY | Grant (A) | +44,124 | $0 | EDGAR |
| 2026-04-17 | INCY | Grant (A) | +39,049 | $0 | EDGAR |
| 2026-01-21 | INCY | Grant (A) | — | $0 | EDGAR |
| 2026-01-07 | INCY | Sell (S) | −15,634 | -$1.59M | EDGAR |
| 2026-01-05 | INCY | Tax (F) | −13,292 | -$1.31M | EDGAR |
| 2025-12-03 | INCY | Mixed | −39,757 | -$4.07M | EDGAR |
| 2025-11-07 | INCY | Mixed | — | -$47.9K | EDGAR |
| 2025-07-23 | INCY | Sell (S) | −3,706 | -$251.8K | EDGAR |
| 2025-07-16 | INCY | Mixed | −5,826 | -$1.24M | EDGAR |
| 2025-07-07 | INCY | Tax (F) | −12,714 | -$866.7K | EDGAR |